Speaker
Description
With over five decades of experience in accelerator-based targetry, TRIUMF also ensures that Canada remains on the leading edge of research and development of high-intensity radiation damage in materials. TRIUMF operates a variety of target systems from 13-500 MeV, kW-class proton targets for medical isotope production to higher power proton and electron beam targets for muon, neutron and rare isotope beam production.
As an example, ISAC-TRIUMF is the only ISOL facility worldwide that is routinely operating targets under particle irradiation in the high-power regime in excess of 10 kW. TRIUMF’s current flagship project ARIEL, Advanced Rare IsotopE Laboratory, will add two new target stations providing isotopes to the existing experimental stations in ISAC I and ISAC II at keV and MeV energies, respectively. In addition to the operating 500 MeV, 50 kW proton driver from TRIUMF’s main cyclotron, ARIEL will make use of a 35 MeV, 100 kW electron beam from a newly installed superconducting linear accelerator, adding the first high-power pulsed beam driver to the suite of accelerator target systems at TRIUMF. This calls for dedicated studies of the combined temperature shock and radiation aging effects in target, structural and functional materials.